• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOVENTUS LLC. DUROLANE; ACID, HYALURONIC, INTRAARTICULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOVENTUS LLC. DUROLANE; ACID, HYALURONIC, INTRAARTICULAR Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pain (1994); Inadequate Pain Relief (2388); Ambulation Difficulties (2544)
Event Date 11/12/2021
Event Type  Injury  
Event Description
I had a durolane (bioventus) injection for knee pain on (b)(6) 2021.That day, i reported to md office that it felt like a bad bruise on the lower inside of my right knee.The left knee (also injected) felt fine.I understood there might be transient pain after injection, and it might take a few weeks for pre-injection discomfort to hopefully lessen, but it's 3 weeks later and my knee has gotten progressively worse.My quality of life is much worse than before the injection.My ability to walk is very hampered with constant limping.I cannot get through the night.Certainly, i had the knee treated because there were issues before, but it is now much worse than it was with constant pain on the inner joint.I have rested, iced, taken otc nsaids.All temporarily helped symptoms, but, again, it's worse day by day.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUROLANE
Type of Device
ACID, HYALURONIC, INTRAARTICULAR
Manufacturer (Section D)
BIOVENTUS LLC.
MDR Report Key12953574
MDR Text Key281927070
Report NumberMW5105859
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 12/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received12/06/2021
Patient Sequence Number1
Treatment
GABAPENTIN ; TAMSULOSIN
Patient Outcome(s) Other;
Patient Age63 YR
Patient SexMale
Patient Weight82 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-